Centre for Global Health Policy

Innovative/Biological Therapies in Sports Injury

On 28th March 2017, the Biosport project team, in conjunction with Professor Ilyas Khan (Swansea University) are bringing together leading scholars, clinicians and practioners in sports medicine along with biotechnology company representatives, medical insurers and trade union reps to discuss and debate the use of innovative and biological therapies in treating sports injuries.

The day will be divided between paper presentations and open discussion sessions around 4 themes:

1. The Biosport project: overview of objectives and findings
2. Orthobiologics: market, science and clinical applications
3. Case studies in injury treatment from professional football and cycling
4. Ethical and welfare issues

Participants include:

Francesco dell'Accio, Queen Mary University

Lars Engbretson, IOC Commission

Vincent Gouttebarge, FIFPro

Paul Anderson, Orthocell

Shaabaz Mughal, Totteham Hotspurs Football Club

Helen Millson, Physiotherapist and medical insurer

Nigel Hawkins, HCA healthcare UK


Summary of discussion (coming soon)
Points for debate (coming soon)


Visit the BIOSPORT project website

View Presentation: 'Orthobiologics in sports medicine: an overview of the market'

Screenshot of the first presentation slide

Follow the BIOSPORT project on Twitter

Visit BIOSPORTproject on Twitter